BEUDAMED
    FDA Adverse Event Injury Summary report: N

    OMNIPOD 5 PODS

    MDR report key: 21526998 · Received March 5, 2025

    Report

    Report Number
    3004464228-2025-09308
    Event Type
    Injury
    Date Received
    March 5, 2025
    Date of Event
    February 1, 2025
    Report Date
    March 5, 2025
    Manufacturer
    INSULET CORPORATION
    Product Code
    QFG
    UDI-DI
    20385083000579
    PMA / PMN Number
    K231826
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    MA, US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO CUSTOMER'S INFUSION SITE INFECTION. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. THE OMNIPOD IS (B)(4) COMPLIANT, UNDERGOING CYTOTOXICITY, SENSITIZATION, GENOTOXICITY, HEMOLYSIS, IRRITATION OR INTRACUTANEOUS REACTIVITY, SYSTEMIC TOXICITY, AND IMPLANTATION EFFECTS TESTING. THE OMNIPOD IS STERILIZED WITH 100% ETHYLENE OXIDE GAS WITH A STERILITY ASSURANCE LEVEL OF 10-6 PER (B)(4) AND EO RESIDUAL LEVELS IN COMPLIANCE WITH (B)(4). EACH LOT IS CONFIRMED TO MEET REQUIREMENTS FOR NON-PYROGENICITY PER (B)(4) AND STERILITY PER (B)(4) PRIOR TO RELEASE. *PLEASE NOTE, THAT SECTION D IS CAPTURING THE DEVICE IDENTIFIERS AS REPORTED BY THE COMPLAINANT. THIS MAY NOT ALIGN TO THE DEVICE CONFIGURATION REPORTED IN H11, AS THIS DATA IS PULLED FROM OUR CLOUD BASED ON THE REPORTED DATE OF EVENT. CLOUD - LOCKED DOWN/SMARTPHONE PHONE_CONTROL_IOS. CLOUD - OMNIPOD 5 SOFTWARE APP VERSION 1.1.6. CLOUD - SMARTPHONE OPERATING SYSTEM 17.6. CLOUD - SMARTPHONE HARDWARE IPHONE14.3. CLOUD - CGM SENSOR TYPE G6.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT THE PATIENT DEVELOPED AN INFECTION AT THE POD¿S INSERTION SITE WHILE WEARING THE DEVICE BETWEEN 4 AND 24 HOURS. THE PATIENT REPORTS HAVING SWELLING, REDNESS, INFLAMMATION AND PURULENT DISCHARGE AT THE POD INFUSION SITE. ONCE AT URGENT CARE THE PATIENT WAS TREATED WITH 2 DIFFERENT ANTIBIOTICS AND RECEIVED ANTIBIOTIC INJECTIONS FOR 3 DAYS. THE PATIENT WAS AT URGENT CARE FOR 2.5-3 HOURS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2276014 OMNIPOD 5 PODS OMNIPOD 5 PODS QFG INSULET CORPORATION PT-001662 PH1K07102421 20385083000579

    Patients

    Seq Age Sex Outcome Treatment
    1 29 YR Male